Robert Rubenzik is a Glendale, Arizona based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Robert Rubenzik is 8924 for Ophthalmology in Arizona. Robert Rubenzik is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Robert Rubenzik speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
6005 W Thunderbird Rd, Glendale, Arizona, 85306-4011
Phone:
602-938-0900
Fax:
602-978-0953
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1407826480
NPI Enumeration Date:
24 Jan, 2006
NPI Last Update On:
13 Aug, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Robert Rubenzik are as mentioned below.
License Number
Specialization
State
Status
8924
Ophthalmology
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6005 W Thunderbird Rd, Glendale, Arizona
Zip:
85306-4011
Phone Number:
602-938-0900
Fax Number:
602-978-0953
Patients can reach Robert Rubenzik at 6005 W Thunderbird Rd, Glendale, Arizona or can call to book an appointment on 602-938-0900. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.